Increased lipoprotein(a) in a paediatric patient associated with nephrotic syndrome

被引:0
作者
Menendez Valladares, Paloma [1 ]
Arrobas Velilla, Teresa [1 ,2 ]
Bermudez de la Vega, Jose Antonio [3 ]
Romero Perez, Maria del Mar [3 ]
Fabiani Romero, Fernando [1 ]
Gonzalez Rodriguez, Concepcion [1 ]
机构
[1] Hosp Univ Virgen Macarena, Unidad Gest Clin Bioquim Clin, Lab Nutr & RCV, Seville, Spain
[2] Univ Autonoma Chile, Fac Med, Providencia, Region Metropol, Chile
[3] Hosp Univ Virgen Macarena, Unidad Gest Clin Pediat, Endocrinol Pediat, Seville, Spain
来源
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS | 2016年 / 28卷 / 05期
关键词
LDL-chotesterol; Lipoprotein(a); Nephrotic syndrome; Paediatrics;
D O I
10.1016/j.arteri.2016.06.006
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
A common complication in paediatric patients with nephrotic syndrome (NS) is hyperlipidaemia. About 20% of children do not respond to treatment with corticosteroids, presenting with a cortico-resistant NS (CRNS), which can progress to kidney failure. It has been observed that paediatric patients with CRNS have an elevated low density lipoprotein cholesterol (LDL-c), very low density lipoprotein cholesterol (VLDL-c) and triglycerides levels, as well as elevated Lipoprotein-a [Lp (a)] levels. The case is presented of a 5 year old boy, diagnosed with CRNS, presenting with dyslipidaemia with increased LDL-c, Apo-B100, and Lp(a) levels. After the poor prognosis of the renal function, immunosuppressant treatment was started with tacrolimus and atorvastatin to control dyslipidaemia. Although tacrolimus causes an elevation of total cholesterol and LDL-c, the significant alterations of the children lipid profile suggest the existence of a high cardiovascular risk. In these cases, it would be interesting to have reference values in children in our health area. (C) 2016 Sociedad Espanola de Arteriosclerosis. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:227 / 229
页数:3
相关论文
共 50 条
  • [1] Lipoprotein (a) as a Predictor of Steroid Dependence in Paediatric Steroid Sensitive Nephrotic Syndrome
    Basu, Surupa
    Banerjee, Sushmita
    Roy, Pranab
    Ghosh, Apurba
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (01)
  • [2] EFFECTS OF SIMVASTATIN ON LIPOPROTEIN(A) AND LIPOPROTEIN COMPOSITION IN PATIENTS WITH NEPHROTIC SYNDROME
    WANNER, C
    BOHLER, J
    ECKARDT, HG
    WIELAND, H
    SCHOLLMEYER, P
    CLINICAL NEPHROLOGY, 1994, 41 (03) : 138 - 143
  • [3] ELEVATED PLASMA LIPOPROTEIN(A) IN PATIENTS WITH THE NEPHROTIC SYNDROME
    WANNER, C
    RADER, D
    BARTENS, W
    KRAMER, J
    BREWER, HB
    SCHOLLMEYER, P
    WIELAND, H
    ANNALS OF INTERNAL MEDICINE, 1993, 119 (04) : 263 - 269
  • [4] Nephrotic Syndrome is Associated with Increased Risk of Ischemic Stroke
    Huang, Jin-An
    Lin, Ching-Heng
    Chang, Yao-Tien
    Lee, Cheng-Ting
    Wu, Ming-Ju
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (11)
  • [5] Lipoprotein metabolism in the nephrotic syndrome
    Marsh, JB
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : E326 - E338
  • [6] LIPOPROTEIN METABOLISM IN THE NEPHROTIC SYNDROME
    WARWICK, GL
    PACKARD, CJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (05) : 385 - 396
  • [7] Nephrotic syndrome in a patient with IgM myeloma with associated neutrophilia
    Gnerre, Paola
    Ottonello, Luciano
    Montecucco, Fabrizio
    Boero, Michela
    Dallegri, Franco
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (01) : 76 - 80
  • [8] ELEVATED LIPOPROTEIN-(A) LEVELS IN PRIMARY NEPHROTIC SYNDROME
    FAUCHER, C
    DOUCET, C
    BAUMELOU, A
    CHAPMAN, J
    JACOBS, C
    THILLET, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (06) : 808 - 813
  • [9] The level of native and oxidized lipoprotein(a) in children with nephrotic syndrome
    Li, Han-qing
    Wu, Jia
    Niu, Dong-Mei
    Shi, Yong-Hui
    Zhang, Chun-ni
    Wang, Jun-jun
    CLINICAL BIOCHEMISTRY, 2012, 45 (1-2) : 101 - 105
  • [10] Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy
    Arai, T
    Yamashita, S
    Yamane, M
    Manabe, N
    Matsuzaki, T
    Kiriyama, K
    Kanayama, Y
    Himeno, S
    Matsuzawa, Y
    ATHEROSCLEROSIS, 2003, 169 (02) : 293 - 299